In 2004, Müller et al. assessed SFRP2 methylation in fecal DNA to diagnose CRC using MethyLight analysis; its sensitivity and specificity were as high as 77% and 77%, respectively, although they analyzed only 13 CRC and 13 control samples 5. This evidence concerns the gene SFRP2 and colorectal carcinoma.